Skip to content
healthcare.dev
Get a free key

OXTELLAR XR

NDC 17772-121, OXCARBAZEPINE, tablet, from Supernus Pharmaceuticals, Inc..

Product NDC
17772-121
Status
Listed
Labeler
Supernus Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA202810
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17772-121 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXCARBAZEPINE150 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
17772-121-0117772012101100 TABLET in 1 BOTTLE (17772-121-01)
17772-121-07177720121077 TABLET in 1 BOTTLE (17772-121-07)
17772-121-10177720121105 TABLET in 1 BLISTER PACK (17772-121-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/aa610e56-1d1d-11e1-8bc2-0800200c9a66

  • NADAC price for package 17772012101

    GET /v1/drugs/nadac/17772012101

Use it

Look up 17772-121 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17772-121 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17772-121. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.